![Combining statins with chemotherapy does not extend survival in lung cancer | UCL Cancer Institute - UCL – University College London Combining statins with chemotherapy does not extend survival in lung cancer | UCL Cancer Institute - UCL – University College London](https://www.ucl.ac.uk/cancer/sites/cancer/files/styles/large_image/public/migrated-images/tablets.jpg?itok=SGg8NcE4)
Combining statins with chemotherapy does not extend survival in lung cancer | UCL Cancer Institute - UCL – University College London
![Abiraterone: a story of scientific innovation and commercial partnership - The Institute of Cancer Research, London Abiraterone: a story of scientific innovation and commercial partnership - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/scientific-imagery/_dsc3824.jpg?sfvrsn=ce919868_11)
Abiraterone: a story of scientific innovation and commercial partnership - The Institute of Cancer Research, London
![Study finds almost half of patients with inoperable pancreatic cancer are not prescribed essential medication - University of Birmingham Study finds almost half of patients with inoperable pancreatic cancer are not prescribed essential medication - University of Birmingham](https://www.birmingham.ac.uk/Images/College-MDS-only/cancer-genomics/news/2021/05/tablets.xfec67d21.jpg)
Study finds almost half of patients with inoperable pancreatic cancer are not prescribed essential medication - University of Birmingham
![South Korea approves phase 3 clinical trials of breast cancer treatment 'Tucatinib' – ThePrint – ANIFeed South Korea approves phase 3 clinical trials of breast cancer treatment 'Tucatinib' – ThePrint – ANIFeed](https://static.theprint.in/wp-content/uploads/2022/04/Untitled-120220419041900.jpg?compress=true)
South Korea approves phase 3 clinical trials of breast cancer treatment 'Tucatinib' – ThePrint – ANIFeed
![Men in England and Wales miss out on abiraterone as first-line treatment for advanced prostate cancer - The Institute of Cancer Research, London Men in England and Wales miss out on abiraterone as first-line treatment for advanced prostate cancer - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/images/default-source/default-album/white-abiraterone-pill-16-9040834cb659564f3a772ff0000325351.jpg?sfvrsn=75925069_2)
Men in England and Wales miss out on abiraterone as first-line treatment for advanced prostate cancer - The Institute of Cancer Research, London
![841 Cancer Drug Stock Photos, Pictures & Royalty-Free Images - iStock | Kidney cancer drug, Ovarian cancer drug, Cancer drug treatment 841 Cancer Drug Stock Photos, Pictures & Royalty-Free Images - iStock | Kidney cancer drug, Ovarian cancer drug, Cancer drug treatment](https://media.istockphoto.com/id/106510451/photo/a-variety-of-medicinal-pills-on-one-hand.jpg?s=612x612&w=0&k=20&c=79aiJDvvaDnvv6LZrk8SZ8SeJ5MsxMZgcU8tcWnMdTw=)